Clinical Trial Update: GITMO AML/MDS-Relapse Registry Study

View source ↗

Summary

The GITMO AML/MDS-Relapse Registry Study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: Gruppo Italiano Trapianto di Midollo Osseo | Conditions: Acute Myeloid Leukaemia, Myelodysplastic Syndrome | Status: COMPLETED